{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:44:36Z","timestamp":1790138676408,"version":"4.0.1"},"reference-count":15,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,27]]},"DOI":"10.1182\/bloodadvances.2022008557","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:47:06Z","timestamp":1666014426000},"page":"6131-6134","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Clofarabine treatment of\n                    <i>KMT2A<\/i>\n                    r infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-7257","authenticated-orcid":false,"given":"Tanja A.","family":"Gruber","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqing","family":"Pei","sequence":"additional","affiliation":[{"name":"2Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-0180","authenticated-orcid":false,"given":"John","family":"Choi","sequence":"additional","affiliation":[{"name":"3Department of Pathology, University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[{"name":"2Department of Biostatistics, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Coustan-Smith","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Campana","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope D.","family":"Swanson","sequence":"additional","affiliation":[{"name":"5Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Pauley","sequence":"additional","affiliation":[{"name":"6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika L.","family":"Metzger","sequence":"additional","affiliation":[{"name":"6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"},{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-3527","authenticated-orcid":false,"given":"Jeffrey E.","family":"Rubnitz","sequence":"additional","affiliation":[{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9956-5647","authenticated-orcid":false,"given":"Raul C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana C.","family":"Raimondi","sequence":"additional","affiliation":[{"name":"8Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-5658","authenticated-orcid":false,"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[{"name":"6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"},{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[{"name":"6Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"},{"name":"7Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"issue":"9583","key":"2023053018350155600_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A\u00a0treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"issue":"25","key":"2023053018350155600_bib2","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1200\/JCO.19.00261","article-title":"Outcome of infants younger than 1 year with acute lymphoblastic leukemia treated with the interfant-06 protocol: results from an international phase III randomized study","volume":"37","author":"Pieters","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"2023053018350155600_bib3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/s41375-021-01177-6","article-title":"FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631","volume":"35","author":"Brown","year":"2021","journal-title":"Leukemia"},{"issue":"35","key":"2023053018350155600_bib4","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude total therapy study 16","volume":"37","author":"Jeha","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2023053018350155600_bib5","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1200\/JCO.2005.03.8554","article-title":"Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia","volume":"24","author":"Jeha","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"2023053018350155600_bib6","author":"Kalbfleisch","year":"2002","edition":"2nd"},{"issue":"3","key":"2023053018350155600_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"issue":"10","key":"2023053018350155600_bib8","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"2023053018350155600_bib9","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9321","key":"2023053018350155600_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the\u00a011q23 chromosomal region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"2023053018350155600_bib11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3324\/haematol.2021.279357","article-title":"Clofarabine increases\u00a0the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group","volume":"107","author":"Escherich","year":"2022","journal-title":"Haematologica"},{"issue":"6","key":"2023053018350155600_bib12","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/cncr.31099","article-title":"Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: a report from the Children's Oncology Group study AALL1131","volume":"124","author":"Salzer","year":"2018","journal-title":"Cancer"},{"issue":"18_suppl","key":"2023053018350155600_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.21134","article-title":"Effect of clofarabine on lymphocyte populations in patients treated for solid tumors","volume":"25","author":"Cunningham","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"1821","key":"2023053018350155600_bib14","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"282","author":"Simon","year":"2015","journal-title":"Proc Biol Sci"},{"key":"2023053018350155600_bib15","first-page":"505","article-title":"Viral infections in hematopoietic stem cell transplant recipients","author":"Ljungman","year":"2009","journal-title":"Allogeneic Stem Cell Transplantation"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/24\/6131\/2054489\/blooda_adv-2022-008557-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/24\/6131\/2054489\/blooda_adv-2022-008557-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:36:59Z","timestamp":1685457419000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/24\/6131\/486815\/Clofarabine-treatment-of-KMT2Ar-infantile-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":15,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2022,12,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008557","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}